uniQure N.V. Depreciation & Amortization 2011-2026 | QURE

Annual Depreciation & Amortization uniQure N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10.1 M	10.3 M	8.2 M	6.1 M	10.6 M	6.67 M	12.4 M	7.54 M	5.5 M	4.4 M	2 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.4 M	2 M	7.62 M

Quarterly Depreciation & Amortization uniQure N.V.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	4.53 M	-	-	-	2.63 M	-	-	-	2.53 M	-	6.21 M	4.1 M	2.12 M	-	5.45 M	3.67 M	1.86 M	-	8.35 M	3.5 M	1.73 M	-	4.93 M	3.22 M	1.57 M	-	10.4 M	3.21 M	1.55 M	-	1.7 M	4.26 M	1.79 M	-	1.4 M	2.99 M	1.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.4 M	1.4 M	3.55 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Adagene ADAG	723 K	$ 1.9	-3.11 %	$ 107 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	5.38 M	$ 2.71	1.88 %	$ 17 M	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.87	-0.79 %	$ 1.25 B	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Bio-Path Holdings BPTH	82 K	-	-	$ 100 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 64.74	1.41 %	$ 8.66 B	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.96	-1.0 %	$ 8.62 B	Israel
CASI Pharmaceuticals CASI	468 K	$ 0.95	-0.72 %	$ 129 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Celldex Therapeutics CLDX	3.18 M	$ 25.15	-1.95 %	$ 1.62 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Catalyst Biosciences CBIO	1.07 M	$ 14.01	3.7 %	$ 922 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	673 M	$ 164.87	0.27 %	$ 24 B	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
BioVie BIVI	229 K	$ 1.23	2.07 %	$ 1.82 M	USA
Catalyst Pharmaceuticals CPRX	397 K	$ 23.32	2.71 %	$ 2.76 B	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA